Recent Finacing
Recent Raise
Tenvie Therapeutics designs and develops brain-penetrant, peripherally restricted small-molecule therapeutics for neurological, cardiometabolic, and ophthalmic indications, advancing NLRP3 and SARM1-targeted programs plus preclinical assets.
